SCHEMBL4028119

SCHEMBL4028119

NC(=O)c1cc2c(-c3ccc(Cl)cc3)n(-c3ccccc3Cl)nc2nc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020895 0.91 CNR2 (0.46) CNR1
SCHEMBL4022535 0.86 CNR1 (0.43) CNR1
SCHEMBL4182880 0.85 CNR2 (0.48) CNR1
SCHEMBL4028124 0.85 CNR2 (0.48) CNR1
SCHEMBL4023265 0.84 CNR1 (0.44) CNR1
SCHEMBL4020287 0.84 CNR2 (0.50) CNR1
SCHEMBL4021990 0.84 CNR1 (0.41) CNR1
SCHEMBL4021985 0.83 CNR1 (0.51) CNR1
SCHEMBL4022082 0.78 CNR2 (0.50) CNR1
SCHEMBL4023477 0.78 CNR2 (0.48) CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009095752-A1 FUSED PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-08-06 WO claimed
WO-2009095752-A1 FUSED PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-08-06 WO disclosed